Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

1.

Tubulin glycylases are required for primary cilia, control of cell proliferation and tumor development in colon.

Rocha C, Papon L, Cacheux W, Marques Sousa P, Lascano V, Tort O, Giordano T, Vacher S, Lemmers B, Mariani P, Meseure D, Medema JP, Bièche I, Hahne M, Janke C.

EMBO J. 2014 Sep 1. pii: e201488466. [Epub ahead of print]

PMID:
25180231
[PubMed - as supplied by publisher]
Free Article
2.

Acquired resistance to endocrine treatments is associated with tumor-specific molecular changes in patient-derived luminal breast cancer xenografts.

Cottu P, Bièche I, Assayag F, El Botty R, Chateau-Joubert S, Thuleau A, Bagarre T, Albaud B, Rapinat A, Gentien D, de la Grange P, Sibut V, Vacher S, Hatem R, Servely JL, Fontaine JJ, Decaudin D, Pierga JY, Roman-Roman S, Marangoni E.

Clin Cancer Res. 2014 Aug 15;20(16):4314-25. doi: 10.1158/1078-0432.CCR-13-3230. Epub 2014 Jun 19.

PMID:
24947930
[PubMed - in process]
3.

Control of MT1-MMP transport by atypical PKC during breast-cancer progression.

Rossé C, Lodillinsky C, Fuhrmann L, Nourieh M, Monteiro P, Irondelle M, Lagoutte E, Vacher S, Waharte F, Paul-Gilloteaux P, Romao M, Sengmanivong L, Linch M, van Lint J, Raposo G, Vincent-Salomon A, Bièche I, Parker PJ, Chavrier P.

Proc Natl Acad Sci U S A. 2014 May 6;111(18):E1872-9. doi: 10.1073/pnas.1400749111. Epub 2014 Apr 21.

PMID:
24753582
[PubMed - indexed for MEDLINE]
4.

Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings.

Bieche I, Vacher S, Vallerand D, Richon S, Hatem R, De Plater L, Dahmani A, Némati F, Angevin E, Marangoni E, Roman-Roman S, Decaudin D, Dangles-Marie V.

BMC Cancer. 2014 Mar 13;14:178. doi: 10.1186/1471-2407-14-178.

PMID:
24625025
[PubMed - in process]
Free PMC Article
5.

PIK3R1 underexpression is an independent prognostic marker in breast cancer.

Cizkova M, Vacher S, Meseure D, Trassard M, Susini A, Mlcuchova D, Callens C, Rouleau E, Spyratos F, Lidereau R, Bièche I.

BMC Cancer. 2013 Nov 14;13:545. doi: 10.1186/1471-2407-13-545.

PMID:
24229379
[PubMed - indexed for MEDLINE]
Free Article
6.

Inhibitory signalling to the Arp2/3 complex steers cell migration.

Dang I, Gorelik R, Sousa-Blin C, Derivery E, Guérin C, Linkner J, Nemethova M, Dumortier JG, Giger FA, Chipysheva TA, Ermilova VD, Vacher S, Campanacci V, Herrada I, Planson AG, Fetics S, Henriot V, David V, Oguievetskaia K, Lakisic G, Pierre F, Steffen A, Boyreau A, Peyriéras N, Rottner K, Zinn-Justin S, Cherfils J, Bièche I, Alexandrova AY, David NB, Small JV, Faix J, Blanchoin L, Gautreau A.

Nature. 2013 Nov 14;503(7475):281-4. doi: 10.1038/nature12611. Epub 2013 Oct 16.

PMID:
24132237
[PubMed - indexed for MEDLINE]
7.

SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.

Jacquemier J, Spyratos F, Esterni B, Mozziconacci MJ, Antoine M, Arnould L, Lizard S, Bertheau P, Lehmann-Che J, Fournier CB, Krieger S, Bibeau F, Lamy PJ, Chenard MP, Legrain M, Guinebretière JM, Loussouarn D, Macgrogan G, Hostein I, Mathieu MC, Lacroix L, Valent A, Robin YM, Revillion F, Triki ML, Seaume A, Salomon AV, de Cremoux P, Portefaix G, Xerri L, Vacher S, Bièche I, Penault-Llorca F.

BMC Cancer. 2013 Jul 22;13:351. doi: 10.1186/1471-2407-13-351.

PMID:
23875536
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A Molecular Predictor Reassesses Classification of Human Grade II/III Gliomas.

Rème T, Hugnot JP, Bièche I, Rigau V, Burel-Vandenbos F, Prévot V, Baroncini M, Fontaine D, Chevassus H, Vacher S, Lidereau R, Duffau H, Bauchet L, Joubert D.

PLoS One. 2013 Jun 21;8(6):e66574. Print 2013.

PMID:
23805239
[PubMed - as supplied by publisher]
Free PMC Article
9.

Variations in the mRNA expression of poly(ADP-ribose) polymerases, poly(ADP-ribose) glycohydrolase and ADP-ribosylhydrolase 3 in breast tumors and impact on clinical outcome.

Bieche I, Pennaneach V, Driouch K, Vacher S, Zaremba T, Susini A, Lidereau R, Hall J.

Int J Cancer. 2013 Dec 15;133(12):2791-800. doi: 10.1002/ijc.28304. Epub 2013 Aug 9.

PMID:
23736962
[PubMed - indexed for MEDLINE]
10.

Rare overexpression of anaplastic lymphoma kinase gene in inflammatory and non-inflammatory breast cancer.

Lerebours F, Callens C, Vacher S, Hatem R, Guinebretière JM, Bièche I.

Eur J Cancer. 2013 Aug;49(12):2774-6. doi: 10.1016/j.ejca.2013.04.010. Epub 2013 May 8. No abstract available.

PMID:
23664096
[PubMed - indexed for MEDLINE]
11.

A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation.

Weiswald LB, Richon S, Massonnet G, Guinebretière JM, Vacher S, Laurendeau I, Cottu P, Marangoni E, Nemati F, Validire P, Bellet D, Bièche I, Dangles-Marie V.

Br J Cancer. 2013 Apr 30;108(8):1720-31. doi: 10.1038/bjc.2013.132. Epub 2013 Mar 28.

PMID:
23538387
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

miRNA expression profiling of inflammatory breast cancer identifies a 5-miRNA signature predictive of breast tumor aggressiveness.

Lerebours F, Cizeron-Clairac G, Susini A, Vacher S, Mouret-Fourme E, Belichard C, Brain E, Alberini JL, Spyratos F, Lidereau R, Bieche I.

Int J Cancer. 2013 Oct 1;133(7):1614-23. doi: 10.1002/ijc.28171. Epub 2013 Apr 13.

PMID:
23526361
[PubMed - indexed for MEDLINE]
13.

microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.

Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B, Amsellem-Ouazana D, Bieche I.

Int J Cancer. 2013 Jun 1;132(11):2479-91. doi: 10.1002/ijc.27949. Epub 2013 Feb 25.

PMID:
23169479
[PubMed - indexed for MEDLINE]
14.

In utero and lactational exposure to vinclozolin and genistein induces genomic changes in the rat mammary gland.

El Sheikh Saad H, Toullec A, Vacher S, Pocard M, Bieche I, Perrot-Applanat M.

J Endocrinol. 2013 Jan 18;216(2):245-63. doi: 10.1530/JOE-12-0395. Print 2013 Feb.

PMID:
23160963
[PubMed - indexed for MEDLINE]
Free Article
15.

Cell death and neuronal differentiation of glioblastoma stem-like cells induced by neurogenic transcription factors.

Guichet PO, Bieche I, Teigell M, Serguera C, Rothhut B, Rigau V, Scamps F, Ripoll C, Vacher S, Taviaux S, Chevassus H, Duffau H, Mallet J, Susini A, Joubert D, Bauchet L, Hugnot JP.

Glia. 2013 Feb;61(2):225-39. doi: 10.1002/glia.22429. Epub 2012 Oct 9.

PMID:
23047160
[PubMed - indexed for MEDLINE]
16.

Identification of new candidate therapeutic target genes in triple-negative breast cancer.

Glénisson M, Vacher S, Callens C, Susini A, Cizeron-Clairac G, Le Scodan R, Meseure D, Lerebours F, Spyratos F, Lidereau R, Bièche I.

Genes Cancer. 2012 Jan;3(1):63-70. doi: 10.1177/1947601912449832.

PMID:
22893791
[PubMed]
Free PMC Article
17.

Proteomic analysis of proteins secreted by Botrytis cinerea in response to heavy metal toxicity.

Cherrad S, Girard V, Dieryckx C, Gonçalves IR, Dupuy JW, Bonneu M, Rascle C, Job C, Job D, Vacher S, Poussereau N.

Metallomics. 2012 Aug;4(8):835-46. doi: 10.1039/c2mt20041d. Epub 2012 Jun 18.

PMID:
22706205
[PubMed - indexed for MEDLINE]
18.

Quantification of PKC family genes in sporadic breast cancer by qRT-PCR: evidence that PKCι/λ overexpression is an independent prognostic factor.

Awadelkarim KD, Callens C, Rossé C, Susini A, Vacher S, Rouleau E, Lidereau R, Bièche I.

Int J Cancer. 2012 Dec 15;131(12):2852-62. doi: 10.1002/ijc.27600. Epub 2012 May 21.

PMID:
22511072
[PubMed - indexed for MEDLINE]
19.

Hedgehog pathway activation in human transitional cell carcinoma of the bladder.

Pignot G, Vieillefond A, Vacher S, Zerbib M, Debre B, Lidereau R, Amsellem-Ouazana D, Bieche I.

Br J Cancer. 2012 Mar 13;106(6):1177-86. doi: 10.1038/bjc.2012.55. Epub 2012 Feb 23.

PMID:
22361633
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups.

Cizkova M, Susini A, Vacher S, Cizeron-Clairac G, Andrieu C, Driouch K, Fourme E, Lidereau R, Bièche I.

Breast Cancer Res. 2012 Feb 13;14(1):R28.

PMID:
22330809
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk